Join

Compare · BJDX vs SYK

BJDX vs SYK

Side-by-side comparison of Bluejay Diagnostics Inc. (BJDX) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BJDX and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • SYK is the larger of the two at $93.70B, about 3080.0x BJDX ($30.4M).
  • Over the past year, BJDX is down 71.2% and SYK is down 10.8% - SYK leads by 60.4 points.
  • SYK has been more active in the news (5 items in the past 4 weeks vs 3 for BJDX).
  • SYK has more recent analyst coverage (25 ratings vs 1 for BJDX).
PerformanceBJDX-71.15%SYK-10.77%
2025-04-28+0.00%2026-04-24
MetricBJDXSYK
Company
Bluejay Diagnostics Inc.
Stryker Corporation
Price
$1.95-2.50%
$327.50-0.63%
Market cap
$30.4M
$93.70B
1M return
-4.41%
-0.03%
1Y return
-71.15%
-10.77%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2021
News (4w)
3
5
Recent ratings
1
25
BJDX

Bluejay Diagnostics Inc.

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

SYK

Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Latest BJDX

Latest SYK